Q3 2025 Earnings Call Transcript March 6, 2025 John Wiley & Sons, Inc. beats earnings expectations. Reported EPS is $0.84, expectations were $0.65. Operator: Good morning, and welcome to Wallace Q3 ...

Research Antibodies Market. The global research antibodies market is on a trajectory of significant expansion, driven by the ...

Histone acetylation has been shown to play a crucial role in memory formation, and histone deacetylase (HDAC) inhibitor sodium butyrate (NaB) has been demonstrated to improve memory performance and ...

NTx appointed Dr. Joan Haab as Chief Operations Officer to lead and further develop the company’s operational functions and ...

Wiley (NYSE: WLY), one of the world’s largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...

MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in ...

Q4 2024 Earnings Call Transcript February 28, 2025 Rapid Micro Biosystems, Inc. reports earnings inline with expectations.

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...